UBM India, the organisers of CPhI / P-MEC India, the leading global pharma trade show and conference, today hosted the 5th edition of PharmaLytica 2018 in Hyderabad at the HITEX Exhibition Center. The two day event was inaugurated by Chief Guest - Dr. Preeti Meena IAS, Director, Drugs Control Administration, Hyderabad; Guest of Honours -Mr. Uday Bhaskar Reddy, Director General, Pharmaceuticals Export Promotion Council (PHARMEXCIL); Dr P V Appaji, Director General Emeritus, Pharmaceuticals Export Promotion Council (PHARMEXCIL); Mr.Avinash Talwar, Director & Head, Global Sourcing (Strategic & Plant) Dr.Reddy’s Laboratories Ltd,Dr.R B Smarta, MD, Interlink Marketing Consultancy, Mr. Yogesh Mudras, Managing Director, UBM India and Mr. Rahul Deshpande, Group Director, UBM India amidst an industry gathering.
PharmaLytica enables the pharmaceutical community procure the current industry trends, innovations and conduct business with Analytical, Laboratory, Machinery, Packaging and other allied Industries. The expo is well supported by associations, including Pharmexcil, Confederation of Indian Pharmaceutical Industry (CiPi) and the Indian Drug Manufacturers’ Association (IDMA).
In the current edition, PharmaLytica is witnessing participation from over 150 exhibitors from across the country including notable industry players such as Kirloskar, Standard Group of Companies, Borosil Glass Works, Bry-Air Asia, Rotomark Innovations, Control Print, Gandhi Automation, Leistung Engineering, Mack Pharmatech, Domino Printech, Autocal Solutions, FLIR Systems, Helios Concrew, Kirloskar Pneumatics, S.K. Pharma Machinery, NPM Machinery, Goel Scientific, GMM Pfaudler, ELGI Equipments, First Source Lab, Apex Chromatography, Valfit Engineers, Integrated Cleanroom Technology, Dumra Machines, Sigma Scientific Glass, among many others.
Looking ahead, from 2019, the expo is set to grow and further expand its reach into the Western region with its strong pharma market by hosting PharmaLytica for the first time in Mumbai. While targeting the South-West market with sectors such as Lab & Analytical, Pharma Machinery & Packaging, PharmaLytica will also launch API and Excipients zone to continue its pre-eminence in this region. This will enhance the exhibition profile as a one stop shop for all end-to-end Pharma solutions under one roof.
Speaking at the launch of the 5th edition of PharmaLytica in Hyderabad, Mr. Yogesh Mudras, Managing Director, UBM India said, “The Indian Pharma economy has been lauded for its rapid growth in recent decades. Within this market, Analytical, Bio-technology, Lab equipments, Pharma Machinery and Pharma Packaging sectors in India are set for amplification owing to quality, research, regulatory and environmental compliances. Therefore, the need of the hour for the Indian pharmaceutical players is to achieve maximum efficiency from the potential of today’s landscape with better product and service offerings. At PharmaLytica, every participant gets an opportunity to pick up on the latest industry trends and innovations as well as network with the Pharma business community offering each other a value proposition. The conference that is being held on the sidelines of the expo, seeks to deepen understanding of the changing landscape in the sector to enable responses to the ongoing market trends.”
“Given our growing and unparalleled offering in the Pharma domain, we are pleased to announce PharmaLytica’ s move to Mumbai in 2019, aiming to add immense value to the strong Western market in addition to the Southern one.” he further added.
Speaking at the occasion, Mr. Uday Bhaskar Reddy, Director General, Pharmaceuticals Export Promotion Council (PHARMEXCIL) said, “In FY 2017-18, Indian Pharma exports grew to USD 17.26 billion. One of the key development to notice is, despite 8% negative growth witnessed in the US market, we still grew positive by 2.92%. There are potential markets to explore like China, South Africa and CIS markets and even if negative growth continues in the US market, the Indian Pharma companies should be confident and focus on growth and explore opportunities in the potential markets”.
A series of insightful sessions and panel discussions convened by industry experts are being organized to discuss the trending subjects in Quality Assurance, Technology, Quality Culture and Regulatory & Compliance Standards in the Pharmaceutical Sector. The conference focuses on the growth phase, challenges and how the industry can again truly distinguish itself in the global pharma industry in the years to come.
Day One (10th August) - “Quality Culture - Revolutionizing Dynamics of Quality Assurance”
Session 1 - “A Smart Pharma Manufacturing for Operational Excellence; Latest in Pharmaceutical, Analytical Lab” - Dr P V Appaji, Former DG, Pharmexcil
Speakers - Dr Devraj Rambhau, Director - Technical, Pulse Pharma, Dr Vishwas Sovani, Founder Director, Pharma wisdom and Mr. M Radhakrishnan, Head-HR, Apex Lab, Chennai.